Weibo
WeChat
BioValley International Immunotherapy Drug Development Congress

You can share it to WeChat via the Qr code.

Events
BioValley International Immunotherapy Drug Development Congress

Enter the applet sharing event using WeChat scan.

Background

In the long history of mans battle against disease,We have achieved many sucesses. However, new diseases and symptoms were reported daily from every corner of the plant and become new threats of human health.Cancer is the most terrible one. From surgery to radiotherapy, chemotherapy to molecularly targeted drugs and now immunotherapy, technological breakthroughs never stop to promote the revolution of cancer treatments.

Immunotherapy is the most promising treatment for cancer in this era. It works by restoring or enhancing the recognition and combat effectiveness of immune cells, exerting their potential, and using immune system to defeat cancer cells.

In 2012, Emily, a girl who had childhood acute lymphoblastic leukemia, tried an immunotherapy called chimerical antigen receptor T-cell (CAR-T) therapy and then become cancer free

In August 2015, former US President Jimmy Carter announced that he is using new immunotherapy to fight malignant melanoma. Four months later, President Carter announced that all four melanomas in the brain have disappeared. On March 22, 2019, President Carter created a record due to the 94 years and 172 days of life expectancy surpassed Bush and becomes the longest-lived president in American history. What cured the President Carter ? It is PD-1 antibody immunotherapy.

The great self-repairing ability of life is always beyond our imagination. Immunotherapy is the new hope of life in this era!

On February 14-15, 2020, “BioValley International Immunotherapy Drug Development Congress” will be hold.

BioValley & Shanghai Medical College of Fudan University & Key Laboratory of Medical Molecular Virology, Ministry of Education and Health, are hereby inviting domestic and foreign industry colleagues to seek the breakthroughs in immunotherapy drug.

Why Choose BioValley Congress ?

Because BioValley International Immunotherapy Drug Development Congress:

1.Integrate the R&D in university and company, follow closely on the source of innovation.

2.Discuss from antibody drugs, therapeutic vaccines, cell therapy to gene therapy.

3.Expose your services and products to 120,000 fans from time to time, not only in one or two days during the conference.

4.Combine the technology, talents and funds. You can finding inspiring projects in road show session.

5.Include more communication opportunities. You can connect with 600+ top experts from domestic and foreign regulatory authorities, related companies and scientific research institutions.


Co-located Forum
2020-02-14
2020-02-15
2020-02-14
08:50 -18:00
Main venue

To seek the breakthroughs in immunotherapy drug development!

To stimulate the immuno system and the potential of life! 

2020-02-14
08:50-09:00

Opening Speech

2020-02-14
09:00-09:40

Current status and development trend of international new immunotherapy

2020-02-14
09:40-10:20

How to combine innate immunity with secondary immunity?

2020-02-14
10:20-10:50

Tea Break

2020-02-14
10:50-11:30

Current status and prospects of the immunotherapy’s drug combination

2020-02-14
11:30-12:10

Panel Discussion: Potential targets of immunotherapy drug and drug initiating strategies

2020-02-14
13:30 -14:10
Forum 1:Antibody Drugs and Therapeutic Vaccines
2020-02-14
13:30-14:10

Case sharing of the R&D journey of 

bispecific antibody drug

2020-02-14
14:10-14:50

Application of single B cell sorting 

technology in antibody discovery

2020-02-14
14:50-15:30

Progress in the development of 

antiviral single domain antibodies

2020-02-14
15:30-16:00

Tea Break

2020-02-14
16:00-16:40

Application and advantages of rabbit 

antibody platform in the development

of new antibody products

2020-02-14
16:40-17:20

R&D opportunities for new ADC drugs

2020-02-14
17:20-18:00

Construction of light and heavy chain 

natural paired antibody library based 

on micro fluidic technology

2020-02-14
13:30 -18:00
Forum 2:Cell and Gene Therapy
2020-02-14
13:30-14:10

Application of nanobodies in CAR-T development

2020-02-14
14:10-14:50

Technological advances of CAR-T treatment for 

solid tumors

2020-02-14
14:50-15:30

R&D progress of  TCRT for solid tumors

2020-02-14
15:30-16:00

Tea Break

2020-02-14
16:00-16:40

Innovative development of dual target CAR-T

2020-02-14
16:40-17:20

Technical bottleneck in NK cell therapy

2020-02-14
17:20-18:00

Advanced application of DC cells in cell therapy 

2020-02-15
09:00 -16:40
Forum 1:Antibody Drugs and Therapeutic Vaccines
2020-02-15
09:00-09:40

Case sharing of joint use of tumor 

immunotherapy drugs

2020-02-15
09:40-10:20

Case sharing of  3-specific antibody 

drugs

2020-02-15
10:20-10:50

Tea Break

2020-02-15
10:50-11:30

Preclinical efficacy evaluation of 

3-specific antibodies

2020-02-15
11:30-12:10

The strategy of screening antibody 

drug against challenging 

transmembrane protein

2020-02-15
13:30-14:10

R&D cases of therapeutic hepatitis 

B vaccine

2020-02-15
14:10-14:50

R&D progress of anti-tumor 

therapeutic vaccine

2020-02-15
14:50-15:20

Tea Break

2020-02-15
15:20-16:00

R&D cases of antihypertensive vaccine

2020-02-15
16:00-16:40

Breakthrough of mRNA individualized 

cancer vaccine

2020-02-15
09:00 -09:40
Forum 2:Cell and Gene Therapy
2020-02-15
09:00-09:40

Technical bottleneck and case sharing of 

oncolytic virus drugs

2020-02-15
09:40-10:20

CMC guidance of oncolytic virus drugs

2020-02-15
10:20-10:50

Tea Break

2020-02-15
10:50-11:30

Preclinical evaluation of oncolytic virus drugs

2020-02-15
11:30-12:10

Pharmacological analysis of oncolytic viruses 

based on single cell sequencing

2020-02-15
13:30-16:40

2nd BioValley Project Road Show 

Co-host: CBV Alliance

If you want to showcase your project, please 

contact: ella.qian@biovalleyclub.com 

Only 6 session!

Opening Speech

Current status and development trend of international new immunotherapy

How to combine innate immunity with secondary immunity?

Tea Break

Current status and prospects of the immunotherapy’s drug combination

Panel Discussion: Potential targets of immunotherapy drug and drug initiating strategies

Case sharing of the R&D journey of 

bispecific antibody drug

Application of single B cell sorting 

technology in antibody discovery

Progress in the development of 

antiviral single domain antibodies

Tea Break

Application and advantages of rabbit 

antibody platform in the development

of new antibody products

R&D opportunities for new ADC drugs

Construction of light and heavy chain 

natural paired antibody library based 

on micro fluidic technology

Application of nanobodies in CAR-T development

Technological advances of CAR-T treatment for 

solid tumors

R&D progress of  TCRT for solid tumors

Tea Break

Innovative development of dual target CAR-T

Technical bottleneck in NK cell therapy

Advanced application of DC cells in cell therapy 

Case sharing of joint use of tumor 

immunotherapy drugs

Case sharing of  3-specific antibody 

drugs

Tea Break

Preclinical efficacy evaluation of 

3-specific antibodies

The strategy of screening antibody 

drug against challenging 

transmembrane protein

R&D cases of therapeutic hepatitis 

B vaccine

R&D progress of anti-tumor 

therapeutic vaccine

Tea Break

R&D cases of antihypertensive vaccine

Breakthrough of mRNA individualized 

cancer vaccine

Technical bottleneck and case sharing of 

oncolytic virus drugs

CMC guidance of oncolytic virus drugs

Tea Break

Preclinical evaluation of oncolytic virus drugs

Pharmacological analysis of oncolytic viruses 

based on single cell sequencing

2nd BioValley Project Road Show 

Registration
Preparation Stage
Registration
End of Event
Choose ticket
Type
Price(¥)
Sales End
Quantity
BioValley International Immunotherapy Drug Development Congress
350
2020-02-15 17:30
Sold Out

Refund Description:
Including forum tickets, 2 self-service meal tickets and meeting materials. Due to the small amount, no invoice can be issued, but a receipt can be issued as a voucher if necessary. If you can't attend the meeting, communicate and return it 2 weeks in advance

Price
0
Exhibitors Register
公司 *
联系人 *
电话 *
邮箱 *
主要展品
您选择的展览方案
给主办方留言
Retrieve E-tickets
Please enter the ticket recipient's email or cell phone
Retrieve